yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35097319-25EA3FE1-8079-4909-9269-FEFA7C0F5D8F
Q35097319-25EA3FE1-8079-4909-9269-FEFA7C0F5D8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35097319-25EA3FE1-8079-4909-9269-FEFA7C0F5D8F
The use of novel agents in the treatment of relapsed and refractory multiple myeloma
P2860
Q35097319-25EA3FE1-8079-4909-9269-FEFA7C0F5D8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35097319-25EA3FE1-8079-4909-9269-FEFA7C0F5D8F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b54c620248ad865ea0668e22595b69577408ff76
P2860
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).